By REUTERS
NYT
The UK's top share index steadied on Wednesday as a fall across mining stocks capped results-driven gains, with GlaxoSmithKline a standout riser after the result of a clinical trial boosted hopes for its HIV business.
Published date: August 15, 2018 at 01:00PM
Reuters
New York Times article
Няма коментари:
Публикуване на коментар